STOCK TITAN

John Malone gains 50.01% voting control of Atlanta Braves (NASDAQ: BATRA)

Filing Impact
(High)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13D/A

Rhea-AI Filing Summary

Atlanta Braves Holdings investor John C. Malone filed an amended Schedule 13D showing he now beneficially holds a majority of the company’s voting power. He owns 557,039 shares of Series A common stock (about 5.4% of that class) and 949,201 shares of Series B common stock (about 97.1% of that class), giving him approximately 50.01% of the voting power in director elections.

Recent purchases include 4,631 and 2,259 Series A shares in November 2025 at prices around $42, 3,669 Series B shares on February 4, 2026 at $48.17, and 35,000 Series A shares on February 5, 2026 at a volume-weighted average price of $44.23. Because he now holds a voting majority, the company will be deemed a “Controlled Company” under Nasdaq rules, and Malone can exert significant influence over the board, major transactions, and other matters requiring shareholder approval.

Positive

  • None.

Negative

  • None.

Insights

Malone’s majority voting stake makes Atlanta Braves a Nasdaq “Controlled Company.”

John C. Malone reports beneficial ownership of 557,039 Series A shares (about 5.4%) and 949,201 Series B shares (about 97.1%). Because Series B carries 10 votes per share and is convertible into Series A, he now controls about 50.01% of the issuer’s voting power.

This status means the issuer will be deemed a “Controlled Company” under Nasdaq Rule 5615, allowing certain governance exemptions. Malone states he has no present plans for major transactions but notes he can significantly influence the board, capital structure, mergers, and other shareholder matters, subject to Major League Baseball rules and existing voting agreements.

The filing also details incremental share purchases in November 2025 and early February 2026, with prices between $41.96 and $48.17 per share. Future intentions are framed as ongoing monitoring and potential buying or selling as he deems appropriate.






If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box.

The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).






SCHEDULE 13D




Comment for Type of Reporting Person:
Note to Row 7: John C. Malone ("Mr. Malone") together with Terence F. McGuirk ("Mr. McGuirk") may be deemed to constitute a "group" within the meaning of Section 13(d) of the Act on account of the Malone Voting Agreement and the Malone LLC Operating Agreement. Mr. Malone expressly disclaims membership in such a group. Note to Rows 7, 9, and 11: Includes 47,585 shares of Atlanta Braves Holdings, Inc.'s (the "Issuer") Series B common stock, par value $0.01 per share (the "Series B Common Stock") held in a revocable trust (the "LM Revocable Trust") with respect to which Mr. Malone and Mr. Malone's wife, Mrs. Leslie Malone ("Mrs. Malone"), are trustees. Mrs. Malone has the right to revoke such trust at any time. Mr. Malone disclaims beneficial ownership of the shares held by the LM Revocable Trust. Note to Rows 7, 9, and 11: Includes 3,669 shares of Series B Common Stock held in a revocable trust (the "JM Revocable Trust") with respect to which Mr. Malone is trustee. Mr. Malone has the right to revoke such trust at any time. Note to Row 7: Includes 887,079 shares of Series B Common Stock held by a limited liability company of which Mr. Malone is a member and which Mr. McGuirk has the sole power to direct the voting with respect to Included Matters pursuant to the Malone Voting Agreement and which Mr. Malone has the sole power to direct the voting with respect to all other matters. Note to Rows 8, 10, and 11: Includes 10,868 shares of Series B Common Stock held by two trusts (the "Trusts") which are managed by an independent trustee (and, in the case of one such Trust, also co-managed by one of Mr. Malone's adult children) and of which the beneficiaries are Mr. Malone's adult children. Mr. Malone has no pecuniary interest in the Trusts, but he retains the right to substitute assets held by the Trusts. Mr. Malone disclaims beneficial ownership of the shares held by the Trusts. Note to Row 13: Calculated based upon the 10,318,187 shares of Series A Common Stock as of October 31, 2025, as reported by the Issuer in its Quarterly Report on Form 10-Q for the quarterly period ended September 30, 2025, filed with the Securities and Exchange Commission on November 5, 2025. At the option of the holder, each share of Series B Common Stock is convertible into one share of Series A Common Stock. Each share of Series B Common Stock is entitled to 10 votes, whereas each share of Series A Common Stock is entitled to one vote. Accordingly, Mr. Malone may be deemed to beneficially own voting equity securities of the Issuer representing approximately 50.01% of the voting power with respect to a general election of directors of the Issuer, calculated based on 10,318,187 shares of Series A Common Stock and 977,751 shares of Series B Common Stock outstanding as of October 31, 2025, as reported by the Issuer in its Quarterly Report on Form 10-Q for the quarterly period ended September 30, 2025, filed with the Securities and Exchange Commission on November 5, 2025. See Item 5. This Amendment No. 5 to the Schedule 13D relates to two series of Common Stock, the Series A Common Stock and the Series B Common Stock. Due to technical limitations of only being able to enter nine alpha numeric characters on the facing sheet of this Amendment No. 5, we are filing two versions of this Amendment No. 5 that amend the same Schedule 13D. The first relates to the Series A Common Stock (CUSIP: 047726104). The second relates to the Series B Common Stock (CUSIP: 047726203).


SCHEDULE 13D


John C. Malone
Signature:/s/ John C. Malone
Name/Title:John C. Malone
Date:02/09/2026

FAQ

What does John Malone’s Schedule 13D/A say about his BATRA ownership?

The filing states John C. Malone beneficially owns 557,039 shares of Series A common stock and 949,201 shares of Series B common stock of Atlanta Braves Holdings, representing about 5.4% of Series A and 97.1% of Series B, based on outstanding share counts disclosed by the company.

How much voting control does John Malone have in Atlanta Braves Holdings (BATRA)?

According to the filing, John C. Malone may be deemed to beneficially own voting equity securities representing approximately 50.01% of the voting power in a general election of directors, combining Series A and high-vote Series B shares on the outstanding base disclosed by the issuer.

Why is Atlanta Braves Holdings now considered a “Controlled Company”?

Because John C. Malone now beneficially holds more than a majority of the outstanding voting securities, the company will be deemed a “Controlled Company” under Nasdaq Rule 5615. This status can allow certain corporate governance exemptions while reflecting Malone’s ability to influence board composition and key decisions.

What recent share purchases by John Malone are disclosed for BATRA?

The filing reports that Malone bought 4,631 and 2,259 Series A shares in November 2025 around $42 per share, 3,669 Series B shares on February 4, 2026 at $48.17, and 35,000 Series A shares on February 5, 2026 at a volume-weighted average price of $44.23.

How are John Malone’s Series A and Series B BATRA holdings structured?

Malone’s holdings include shares held directly, in revocable trusts, a limited liability company, a family foundation, and certain trusts for his adult children. He disclaims beneficial ownership of some trust and foundation shares, while still reporting them for Schedule 13D purposes under SEC rules.

Does John Malone outline specific plans for Atlanta Braves Holdings in this filing?

Malone states he currently has no present plans or proposals for actions such as mergers, major asset sales, changes to the board size, or charter changes, apart from what is described and a previously reported Form 8-K. He indicates he will continue monitoring conditions and may buy or sell shares as he deems appropriate.
Atlanta Braves Holdings, Inc

NASDAQ:BATRK

BATRK Rankings

BATRK Latest News

BATRK Latest SEC Filings

BATRK Stock Data

2.47B
55.63M
10.84%
87.86%
1.66%
Entertainment
Services-amusement & Recreation Services
Link
United States
ATLANTA